Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1997 1
1998 1
1999 2
2000 2
2001 4
2002 3
2003 2
2004 7
2005 4
2006 4
2007 6
2008 4
2009 3
2010 6
2011 1
2012 6
2013 4
2014 6
2015 6
2016 4
2017 5
2018 10
2019 3
2020 6
2021 8
2022 14
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Parkinson's disease therapy: what lies ahead?
Wolff A, Schumacher NU, Pürner D, Machetanz G, Demleitner AF, Feneberg E, Hagemeier M, Lingor P. Wolff A, et al. Among authors: feneberg e. J Neural Transm (Vienna). 2023 Jun;130(6):793-820. doi: 10.1007/s00702-023-02641-6. Epub 2023 May 5. J Neural Transm (Vienna). 2023. PMID: 37147404 Free PMC article. Review.
TDP-43 Proteinopathy Specific Biomarker Development.
Cordts I, Wachinger A, Scialo C, Lingor P, Polymenidou M, Buratti E, Feneberg E. Cordts I, et al. Among authors: feneberg e. Cells. 2023 Feb 12;12(4):597. doi: 10.3390/cells12040597. Cells. 2023. PMID: 36831264 Free PMC article. Review.
Towards a TDP-43-Based Biomarker for ALS and FTLD.
Feneberg E, Gray E, Ansorge O, Talbot K, Turner MR. Feneberg E, et al. Mol Neurobiol. 2018 Oct;55(10):7789-7801. doi: 10.1007/s12035-018-0947-6. Epub 2018 Feb 19. Mol Neurobiol. 2018. PMID: 29460270 Free PMC article. Review.
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't.
Lingor P, Demleitner AF, Wolff AW, Feneberg E. Lingor P, et al. Among authors: feneberg e. J Neural Transm (Vienna). 2022 Sep;129(9):1155-1167. doi: 10.1007/s00702-022-02500-w. Epub 2022 Apr 17. J Neural Transm (Vienna). 2022. PMID: 35434769 Free PMC article. Review.
Tackling Disorder in γ-Ga2 O3.
Ratcliff LE, Oshima T, Nippert F, Janzen BM, Kluth E, Goldhahn R, Feneberg M, Mazzolini P, Bierwagen O, Wouters C, Nofal M, Albrecht M, Swallow JEN, Jones LAH, Thakur PK, Lee TL, Kalha C, Schlueter C, Veal TD, Varley JB, Wagner MR, Regoutz A. Ratcliff LE, et al. Among authors: feneberg m. Adv Mater. 2022 Sep;34(37):e2204217. doi: 10.1002/adma.202204217. Epub 2022 Aug 17. Adv Mater. 2022. PMID: 35866491
[New aspects of symptomatic MS treatment: Part 5 - fatigue].
Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG. Henze T, et al. Among authors: feneberg w. Nervenarzt. 2018 Apr;89(4):446-452. doi: 10.1007/s00115-017-0442-8. Nervenarzt. 2018. PMID: 29079869 Review. German.
117 results